REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 151 filers reported holding REVOLUTION MEDICINES INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,329 | +27.0% | 228,661 | +22.7% | 0.00% | +33.3% |
Q2 2023 | $4,984 | +55.5% | 186,325 | +25.9% | 0.00% | +200.0% |
Q1 2023 | $3,205 | -5.2% | 147,949 | +4.2% | 0.00% | -50.0% |
Q4 2022 | $3,382 | -99.9% | 141,999 | -16.4% | 0.00% | -50.0% |
Q3 2022 | $3,351,000 | +460.4% | 169,917 | +454.2% | 0.00% | – |
Q2 2022 | $598,000 | -37.8% | 30,661 | -18.7% | 0.00% | -100.0% |
Q1 2022 | $962,000 | – | 37,713 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |